U.S. Draft Executive Order “More Bark Than Bite”: Will Chinese Innovative-Drug BD Deals Still Benefit Long-Term?China Finance Tech in China3SBio, Biotech, CSPC Pharmaceutical Group, FDA, GSK, Hebo Pharmaceuticals, Hengrui, Pharmaceuticals September 12, 2025
China’s Medical Device Exports are Booming: A Deep Dive into FDA-Approved Stents & The Next Big Investment WaveChina Finance China Hardware Tech in ChinaExports, FDA, Frost & Sullivan, Golden Credit Securities, Investment, Medical Devices, Sinocare Medical, SinoShenchang August 9, 2025
